Paul Leger is a Senior Research Scientist in Medicinal Chemistry at Iambic Therapeutics, a position they have held since 2024. Previously, Paul worked as a Scientist II in Medicinal Chemistry at Takeda from 2022 to 2024, and as a Scientist at RAPT Therapeutics from 2017 to 2019, where they contributed to the design and synthesis of small molecules for immuno-oncology. Paul earned a PhD in Organic Chemistry from the University of California, Berkeley, in 2016, and a Bachelor of Arts in Chemistry from Grinnell College in 2012.
This person is not in the org chart
This person is not in any teams
This person is not in any offices